#1: Reactivates the Fat Cushion Directly Under Your Eye
The fat cells under your eye don't disappear. They go dormant. Dormant can be woken up. Gone cannot.
Inside the orbital fat pad — the cushion directly responsible for that hollow — there are pre-adipocytes that never fully developed, and deflated cells that stopped producing lipid. Neither group is gone. They're waiting for a signal they're not getting.
The signal is a biological switch called PPARgamma. When it activates, immature cells mature. Dormant cells refill with lipid. The cushion rebuilds from the inside, using cells that were already there the whole time.
In 2013, a French lab called Sederma patented a molecule that activates PPARgamma through skin. It's called Volufiline. The active compound — sarsasapogenin — comes from a Chinese herb used for centuries to treat fevers. Researchers found it doing something entirely different in the body. Nothing to do with skin, nothing to do with beauty.
Sederma patented it as a needle-free alternative to breast implants and lipofilling surgery. Built from the beginning to work through skin. No injection. No surgeon. No downtime.
They ran a 57-day clinical study. 5% concentration. Twice daily. Volumetric imaging — not self-reported, not "my skin feels plumper." Equipment that measures. The average result across all participants: +21.4% volume increase.
At the cellular level: +641% increase in lipid storage inside fat cells. 22x growth in individual cell volume. That's not a surface effect. That's the cushion itself rebuilding.
Deep Fill is dosed at the exact 5% concentration from Sederma's study. Not 2%. Not 1% with "Volufiline" on the label. The clinical dose. Because that's the dose with the data behind it.
"I've been using eye creams since I was 30. I'm 48. I have never seen my under-eyes look like this. The hollow is filling. I can see it. I thought I'd need filler. I don't think I need filler anymore."